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Background and purpose Over the decades, improvements in 
surgery and perioperative routines have reduced the incidence 
of deep infections after total hip arthroplasty (THA). There is, 
however, some evidence to suggest that the incidence of infec-
tion is increasing again. We assessed the risk of revision due to 
deep infection for primary THAs reported to the Norwegian 
Arthroplasty Register (NAR) over the period 1987-2007. 
Method We included all primary cemented and uncemented 
THAs reported to the NAR from September 15, 1987 to January 
1, 2008 and performed adjusted Cox regression analyses with the 
first revision due to deep infection as endpoint. Changes in revi-
sion rate as a function of the year of operation were investigated. 
Results Of the 97,344 primary THAs that met the inclusion 
criteria, 614 THAs had been revised due to deep infection (S-year 
survivaI99.46%). Risk of revision due to deep infection increased 
throughout the period studied. Compared to the THAs implanted 
in 1987-1992, the risk of revision due to infection was 1.3 times 
higher (9S%CI: 1.11-1.7) for those implanted in 1993-1997, 1.5 
times (95% Cl: 1.2-2.0) for those implanted in 1998-2002, and 
3.0 times (95% Cl: 2.2-4.0) for those implanted in 2003-2007. 
The most pronounced increase in risk of being revised due to 
deep infection was for the subgroup of uncemented THAs from 
2003-2007, which had an increase of 5 times (95% Cl: 2.6-11) 
compared to uncemented THAs from 1987-1992. 
Interpretation The incidence of deep infection after THA 
increased during the period 1987-2007. Concomitant changes in 
confounding factors, however, complicate the interpretation of the 
results. 
• 
Improvements in surgical technique, perioperative routines, 
and prophylactic measures have reduced the incidence of 
infection from 5-10% in the late 1960s (Charnley 1972) to 
around 1% (Gaine et al. 2000, Zimrnerli and Ochsner 2003, 
Phillips et al. 2006). There is, however, some evidence to sug-
gest that the incidence of infection is increasing (Kurtz et al. 
2008). Few publications have addressed time trends concern-
ing postoperative infections after THAs, and large numbers of 
primary THAs are required to show changes in risk of infec-
tion. We assessed whether there have been any changes in risk 
of revision due to deep infection for THAs reported to the 
Norwegian Arthroplasty Register over the last 2 decades. 
Patients and methods 
Since its inception on September 15, 1987, the Norwegian 
Arthroplasty Register (NAR) has registered detailed data on 
primary THAs and THA revisions in Norway. The data gath-
ered include information on patient identity, date of operation, 
indication for surgery, type of implant, method of fixation, 
duration of surgery, type of operating room ventilation, and 
the type of antibiotic prophylaxis used. The unique identifica-
tion number of each inhabitant of Norway is used to link the 
primary THA to any revision (Havelin et al. 2000). Revision 
due to deep infection of the implant is defined as removal or 
exchange of the whole or parts of the prosthesis, with deep 
infection reported as the diagnosis . Isolated soft tissue revi-
sions are not reported to the register. The register form is filled 
in by the surgeon immediately after surgery. 
The period of inclusion and observation in this study was 
from the start of the NAR on September 15, 1987 to Janu-
ary 1,2008. For this time period, the NAR contained data on 
110,882 primary THAs. In order to have homogeneous sub-
groups concerning type of fixation, 4,392 hybrids and 3,727 
reversed hybrids were excluded. 3,730 arthroplasties had 
incomplete data on fixation method or were registered with 
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different brands of cement for different components, and were 
also excluded. 1,689 additional THAs were excluded because 
of missing values for other adjustment variables. There were 
97,344 THAs with complete information where both compo-
nents were either cemented or uncemented, and these were 
eligible for analysis. 
All THAs were followed until their ﬁrst revision due to 
deep infection or revision for other causes, until date of death 
or emigration of the patient, or until January 1, 2008. Thus, 
follow-up was 0–20 years. 4 time periods were compared: 
1987–1992, 1993–1997, 1998–2002, and 2003–2007, with 
subanalyses on cemented and uncemented THAs. 
As a control, we performed a subanalysis on Charnley pros-
theses ﬁxed with antibiotic-loaded bone cement and given 
antibiotic prophylaxis systemically. This prosthesis was the 
most used in Norway from 1987 to 2008, and it was used 
extensively throughout the whole period of observation. 
Statistics
Survival analyses were performed with a Cox regression 
model, with time period as main risk factor and revision due to 
deep infection as the endpoint. Revision rate ratios (RRs) for 
the time periods are presented with 95% conﬁdence interval 
(CI) and p-values relative to the ﬁrst time period. We adjusted 
for differences over time concerning sex, age (< 40, 40–59, 
60–69, 70–79, r 80 years), diagnosis (osteoarthritis, inﬂam-
matory disease, other), monoblock or modular prosthesis, type 
of ﬁxation (uncemented, cemented with cement containing or 
not containing antibiotics), antibiotic prophylaxis systemi-
cally (yes, no), type of operation room ventilation (ordinary, 
laminar ﬂow, greenhouse), and duration of surgery (< 70, 
70–99, 100–129, orr 130 min). Cox regression analyses with 
time period as stratiﬁcation factor were used to construct 
cumulative revision curves (1 minus cumulative survival) at 
mean values of the covariates, and to assess 5-year survival 
percentages. We also performed a separate Cox analysis with 
revision due to aseptic loosening as endpoint for all THAs, 
in order to be able to compare these ﬁndings with our ﬁnd-
ings for revision due to deep infection. Furthermore, to ensure 
similar potential follow-up for operations in all time periods, 
additional analyses were performed with follow-up restricted 
to 0–5 years.
We also investigated changes in the revision rate due to deep 
infection as a function of year of operation. These analyses 
gave a graphical display of the relationship based on a gener-
alized additive model for survival data (Hastie and Tibshirani 
1990). The curves are presented with 95% CI. 
Risk ratio analyses were performed for the different risk 
factors and prophylactic measures for each time period sepa-
rately, and for the whole 20-year period adjusted for year of 
primary surgery.
 Values of p less than 0.05 were considered statistically sig-
niﬁcant. We used SPSS software version 15.0.
Results 
97,344 primary THAs in 79,820 patients met the inclusion 
criteria for this study. 614 ﬁrst revisions due to deep infection 
were reported in 610 patients. The 5-year survival was 99.46% 
with revision due to deep infection as endpoint. 
The distribution of patient characteristics such as sex, age, 
and diagnosis of patients undergoing primary THA was stable 
throughout the period studied (Table 1), except for the group 
of primary uncemented THAs, where mean age increased from 
52 (SD 12) in 1987–1992 to 61 (SD 13) in 2003–2007. There 
was a shift from monoblock towards modular THAs (Table 1). 
Duration of surgery decreased slightly, whereas the use of an 
operating room with laminar air ﬂow increased through the 
4 time periods (Table 1). Antibiotic-loaded bone cement was 
used more extensively, and cement containing antibiotics was 
used in most cemented THAs towards the end of the study 
period (Table 1). Except during the ﬁrst time period, prophy-
lactic antibiotics were administered systemically in almost all 
operations (Table 1). 
Table 1. Primary THAs included over the four 5-year time periods
Variable  1987–1992  1993–1997  1998–2002  2003–2007
No. of THAs   20,913  22,519  26,230  27,682
Sex (%) 
 Male  30  30  29  31
 Female  70  70  71  69
Age (%) 
 < 40   2  2  2  1
 40–59   15  14  15  14
  60–69  31  27  26  26
  70–79  41  43 41  39
   r 80  12  14  17  19
Diagnosis (%) 
 Osteoarthritis  67  70  73  77
  Inﬂammatory  4  4  4  3
   Other  29  26  23  20
Prosthesis (%) 
 Monoblock  58  53  38  22
  Modular  42  47  62  78
Duration (min) of  
  surgery (%)
 < 70   11  10  11  15
  70–99  41  45  45  45
  100–129  31  31  31  29
   r 130  18  15  13  12
Operation room  
  ventilation (%) 
 “Greenhouse”  12  2  1  1
 Laminar ﬂow  29  45  53  56
  Ordinary  59  53  46  44
Antibiotic prophylaxis 
  systemically (%) 
 No  8  0  0  0
 Yes  92  100  100  100
Method of ﬁxation (%) 
 Uncemented  15  15  14  16
  Cement  
    with antibiotics  38  56 82  83
    without antibiotics  48  29  4  2
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Time trend: deep infection
For all primary THAs, we found an increase in the risk of 
revision due to deep infection, compared to the time period 
1987–1992, for all 3 of the other consecutive time periods. 
The risk of revision due to infection was 1.3 times higher for 
1993–1997, 1.5 times higher for 1998–2002, and 3.0 times 
higher for 2003–2007, respectively (Table 2, Figure 1). The 
risk of infection increased throughout the whole period of 
observation (Figure 2).
In the cemented group of primary THAs, with revision due 
to deep infection as endpoint, we found the same pattern of 
gradual increase in revision risk over time (Table 2, Figures 
1 and 2). This was also found in the subgroup of Charnley 
prostheses ﬁxed with antibiotic-loaded bone cement and given 
antibiotic prophylaxis systemically (Table 2). 
Uncemented THAs had a 5.3 times higher risk of being 
revised due to deep infection in the last time period com-
pared to 1987–1992 (Table 2, Figure 1). The 5-year survival 
(98.94%) was also inferior to that of the cemented group 
(99.20%) for this period (difference = 0.26%, CI: 0.22–0.30, 
p < 0.001). The increase in risk of revision due to deep infec-
tion was most pronounced after the year 2000 for uncemented 
THAs (Figure 2). 
We had 0–20 years of follow-up in our study, but maximum 
follow-up varied for THAs in the different time periods. To 
determine whether this would have inﬂuenced the results, 
analyses were performed including only 0–5 year follow-up 
for each group. This did not change the ﬁndings. 
Time trend: aseptic loosening 
There were 4,437 primary THAs revised due to aseptic loos-
ening in the entire period studied. The percentage revised due 
to aseptic loosening decreased signiﬁcantly throughout the 
period (Figure 3). Relative to the time period 1987–1992, the 
risk of revision due to aseptic loosening was 0.4 times (CI: 
0.3–0.4) for the time period 1998–2002 (p < 0.001) and 0.3 
times (CI: 0.3–0.4) for 2003–2007 (p < 0.001). There was no 
statistically signiﬁcant difference between the 2 latter time 
periods concerning risk of revision due to aseptic loosening 
(Figure 3).
 
Impact of risk factors and prophylactic measures on 
deep infection 
We assessed the effect of the different risk factors and pro-
phylactic measures that were adjusted for in the Cox analysis. 
These factors were adjusted for year of index surgery to adjust 
for unknown confounding and time-dependent factors. 
Male sex was a signiﬁcant risk factor for revision due to 
deep infection, but age and diagnosis did not inﬂuence the 
risk (Table 3). Laminar air ﬂow was associated with a higher 
risk of revision due to infection postoperatively compared to 
ordinary ventilation (Table 3). There was also a higher risk of 
revision due to infection in the groups with an operating time 
of more than 100 min (Table 3). Uncemented THAs and THAs 
implanted with plain cement had a statistically signiﬁcantly 
higher risk of revision due to infection compared to cemented 
THAs ﬁxed with antibiotic-loaded cement (Table 3). Exclu-
sion of monoblock prostheses from the cemented group did 
not alter these ﬁndings. In the small group of patients who 
did not receive antibiotic prophylaxis systemically, we found a 
60% higher risk of THAs being revised due to infection (Table 
3). Subanalyses of the risk factors and prophylactic measures 
performed for each time period separately showed similar 
effects in all 4 time periods. 
Comparison of unadjusted and adjusted risk estimates for 
the 4 time periods showed that different covariates acted as 
Table 2. Risk ratios and 5-year survival estimates for revision due to deep infection. The risk ratios and 
survival estimates are adjusted for sex, age, diagnosis, prosthesis, operation room ventilation, duration 
of operation, and antibiotic prophylaxis
Prosthesis  Time period  No. of THAs   No. of THAs   Risk   p-value  95% CI  5-year 
  included revised due ratio   survival
   to infection
All THAs  1987–1992  20,913  134  1     99.7
  1993–1997  22,519  156  1.3  0.03  1.0–1.7  99.6
  1998–2002  26,230  150  1.5  0.003  1.2–2.0  99.5
   2003–2007  27,682  174  3.0  < 0.001  2.2–4.0  99.1
Cemented THAs 1987–1992  17,867  119  1        99.7
  1993–1997  19,191  133  1.3  0.04  1.0–1.7 99.5
   1998–2002  22,558  129  1.5  0.008  1.1–2.1  99.5
    2003–2007  23,380  136  2.7  < 0.001  1.9–3.7  99.2
Uncemented THAs 1987–1992  3,046  15  1        99.8
   1993–1997  3,328  23  1.2  0.6  0.6–2.4  99.8
   1998–2002  3,672  21  1.4  0.3  0.7–2.9  99.6
    2003–2007  4,302  38  5.3  < 0.001  2.6–10.7  98.9
Charnley with  1987–1992  4,321  26  1        99.7
antibiotics   1993–1997  7,776  46  1.1  0.6  0.7–1.9  99.6
in the cement  1998–2002  9,301  44  1.1  0.9  0.6–1.8  99.6
and systemically  2003–2007  5,925  37  2.0  0.02  1.1–3.5  99.3
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Figure 1. Percentage revision due to deep infection, for all THAs, for cemented THAs, and for uncemented THAs, for 4 periods of primary surgery, 
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Figure 3. Percentage revision due to aseptic loosening, for 
all THAs, for 4 periods of primary surgery, adjusted for sex, 
age, diagnosis, prosthesis, operation room ventilation, dura-
tion of operation, type of ﬁxation, and antibiotic prophylaxis.
Figure 2. Graphical display of the relationship between year of primary surgery 
and risk of revision due to deep infection (with 95% CI) for all THAs, cemented 
THAs, uncemented THAs, and Charnley THAs with uniform antibiotic prophy-
laxis, adjusted for sex, age, diagnosis, prosthesis, operation room ventilation, 
duration of operation, type of ﬁxation, and antibiotic prophylaxis.
confounders for cemented and uncemented THAs. 
Comparing the ﬁrst and the last time period for 
cemented THAs, the risk of revision due to infection 
increased from 1.8 (CI: 1.4–2.3) (p < 0.001) to 2.7 
(CI: 1.9–3.7) (p < 0.001). This change was mainly 
due to adjustment for use of cement containing anti-
biotics and explained by increased use over time and 
the protective ability of cement containing antibiot-
ics. There was also a trend of shorter duration of sur-
gery having a protective effect on cemented THAs. 
For Charnley prostheses inserted with cement con-
taining antibiotics, the effect of adjustment was neg-
ligible. For uncemented THAs, the risk of revision 
due to infection was reduced from 5.7 (CI: 2.9–11.2) 
(p < 0.001) to 5.3 (CI: 2.6–10.7) (p < 0.001) for the 
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last time period relative to the ﬁrst. The decrease was caused 
by adjustment for sex. 
Discussion
Our main ﬁnding was an increased risk of revision due to deep 
infection after primary THA for the 3 consecutive 5-year peri-
ods after 1987–1992. The most pronounced increase was for 
the last time period. The increase was particularly high in the 
subgroup of uncemented THAs. 
We have found no reports on an increased risk of infection 
for primary THAs. Kurtz et al. (2008) report a 2-fold increase 
in overall incidence of deep infection after THA from 0.66% 
in 1990 to 1.23% in 2004. This study on “total infection 
burden” was based on aggregated data, and both primary and 
revision arthroplasties were included in the analyses. For pri-
mary THAs only, they found a reduced incidence of infection. 
Mannien et al. (2008) also reported a 60% decrease in surgical 
site infection after THA between 1996 and 2006 in the Dutch 
national nosocomial surveillance network (PREZIES). The 
Cochrane collaboration has not evaluated THA infections. 
To our knowledge, the ﬁnding that uncemented THAs 
have shown a larger increase in infection rate than cemented 
THAs in recent years has not been described previously. The 
most pronounced increase in risk of revision due to infection 
in uncemented THAs was after the year 2000. Engesaeter 
et al. (2006) concluded in their study from the Norwegian 
Arthroplasty Register, including THAs from the period 1987–
2003, that the risk of revision due to infection was the same 
for uncemented THAs and THAs ﬁxed with cement-contain-
ing antibiotics. THAs ﬁxed with cement without antibiotics 
had a higher risk of deep infection. Based on our study, we 
have reason to believe that there is now a trend towards higher 
susceptibility to deep infection for uncemented THAs than 
for THAs implanted with cement-containing antibiotics. This 
conﬁrms earlier ﬁndings that antibiotic-loaded bone cement 
protects against infection (Engesaeter et al. 2003, Block and 
Stubbs 2005, Parvizi et al. 2008b).
One possible explanation for the increased risk of infec-
tion could be that THA is now performed on patients with 
more comorbidity. Obesity and diabetes have an increasing 
incidence in the population, and these conditions are both risk 
factors for postoperative surgical site infections (Olsen et al. 
2008, Pulido et al. 2008). These factors are not reported to our 
register, but if our material is similar to the general population, 
this could contribute to the increased risk of infection. Another 
independent risk factor is a higher American Society of Anes-
thesiologists score (ASA score) (Ridgeway et al. 2005, Pulido 
et al. 2008). In our register, ASA score was registered from 
2005; thus, we only have data from the last 3 years of the study 
period (The Norwegian Arthroplasty Register 2008). During 
this short period, however, we found an increase in patients 
with higher ASA scores. There was an increase in mean age 
from the ﬁrst to the last time period for the uncemented THAs, 
but this was adjusted for in the analyses. However, age was not 
found to be a statistically signiﬁcant risk factor concerning 
risk of revision due to infection.
Parvizi et al. (2008a) reported on “the changing organism 
proﬁle in periprosthetic infection”, which is another risk factor 
not recorded in the NAR. The microbes causing peripros-
thetic infections could have become more virulent or resis-
tant (Styers et al. 2006, Anderson et al. 2007). More extensive 
use of antibiotic prophylaxis systemically and in bone cement 
may have resulted in selection of more virulent or resistant 
microbes (Santos Sanches et al. 2000). 
The clinical presentation of aseptic loosening and low-
grade periprosthetic infection can be similar (Ince et al. 2004). 
Table 3. Number of primary THAs included and number of reported 
ﬁrst revisions due to deep infection. Adjusted risk ratio estimates 
for sex, age, diagnosis, type of prosthesis, duration of operation, 
operation room ventilation, antibiotic prophylaxis systemically, and 
type of ﬁxation. The risk factors are adjusted for all the other risk 
factors in addition to year of surgery
  No. of THAs  Risk   p-value  95% CI
 included revised ratio
    due to
  infection
Sex 
 Male  29,216  311  2.5  < 0.001  2.1–2.9
   Female  68,128  303  1    
Age 
 < 40  1,721  9  0.5  0.1  0.3–1.1
  40–59  14,240  95  0.8  0.2  0.6–1.1
  60–69   26,336  196  1.1  0.3  0.9–1.3
  70–79   39,812  241  1  
  r 80   15,235  73  0.9  0.5  0.7–1.2
Diagnosis 
 Osteoarthritis  70,134  440  1    
  Inﬂammatory  3,522  22  1.1  0.6  0.7–1.7
   Other  23,688  152  1.2  0.1  1.0–1.4
Prosthesis 
 Modular  57,374  332  0.8  0.1  0.7–1.0
  Monoblock  39,970  282  1  
Duration of 
 surgery, min
 < 70   11,334  55  0.9  0.5  0.7–1.2 
 70–99   42,700  236  1  
  100–129   29,679  211  1.3  0.01  1.0–1.5
  r 130  13,631  112  1.5  0.001  1.2–1-9
Operation room 
ventilation  
 Greenhouse  3,386  30  1.3  0.2  0.9–2.0
 Laminar ﬂow  45,620  324  1.3  0.006  1.1–1.5
  Ordinary  48,338  260  1  
Antibiotic prophylaxis 
systemically 
 No  1,820  15  1.6  0.1  0.9–2.7   
 Yes  95,524  599  1
Method of ﬁxation 
 Uncemented  14,348  97  1.4  0.03  1.0–1.8
  Cement  
   with antibiotics  65,005  360  1    
   without antibiotics  17,991  157  1.9  < 0.001  1.5–2.3
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After revision surgery the diagnosis, reported immediately 
after surgery, will be based on preoperative blood and bac-
terial samples and peroperative evaluation by the surgeon. 
Unexpectedly positive peroperative bacterial cultures will be 
recognized postoperatively and are not reported to NAR. An 
incorrect reported diagnosis will therefore not be corrected in 
the register. Improved diagnostics and knowledge about the 
ability of microbes to cause infection would only affect our 
results if, with time, preoperative bacterial detection improved 
or changed surgeons’ evaluation of the clinical diagnosis.
There have been improvements in procedures for diagnosis 
of periprosthetic infection, and more standardized techniques 
of sampling, culture, and analysis lead to less samples being 
false negative (Dempsey et al. 2007, Moojen et al. 2007, Neut 
et al. 2007). Also, bacteria such as Staphylococcus epidermidis 
have emerged as important agents of implant infection (Neu 
1994, Raad et al. 1998, von Eiff et al. 2006, Anderson et al. 
2007). Earlier in the period studied, these species were consid-
ered to be incapable of causing infections. This may have led 
to deep infection being suspected, and therefore reported, more 
frequently in recent years. The magnitude of this shift remains 
unclear, but with 4,437 revisions due to aseptic loosening and 
only 614 revisions due to infection, even small improvements 
in diagnostics and in our understanding of low-grade infec-
tions may have had an inﬂuence on the results. However, we 
found no change in percentage revision due to aseptic loosen-
ing between the last 2 time periods, whereas it was between 
these two time periods that we found the greatest increase in 
percentage revision due to deep infection (Figure 3).
We do not have information on what time the systemically 
administered antibiotics were given prior to surgery, or if there 
were changes in this routine over time. This has been shown 
to be of importance concerning the protective ability of antibi-
otic prophylaxis (van Kasteren et al. 2007). These factors may 
have inﬂuenced our results.
Because of the large numbers and the long period of obser-
vation, registry studies on deep infection can be a useful source 
of information regarding incidences and trends. The NAR has 
good-quality, detailed information about patients, primary 
surgery, and prophylactic measures, gathered uniformly over 
a long period of time. Our data are prospective, with 95–97% 
completeness for primary THA (Havelin 1995, Espehaug et al. 
2006). We therefore have an excellent basis for a trend study 
on a relatively rare complication like periprosthetic infection. 
However, with 97,344 THAs available for analysis, there were 
only 614 revisions due to infection available for analysis. This 
restricts division into subgroups, and when this is done, mar-
ginal effects are difﬁcult to assess. 
Registry results are inﬂuenced by confounding factors. 
Changes in reporting, revision policy, diagnostics, surgeon 
awareness and surgery, selection of patients, and the virulence 
of microbiotic agents will also inﬂuence the results. These fac-
tors can only be partially elucidated. Completeness studies on 
the NAR have shown that there is 10–20% under-reporting 
of Girdlestone procedures, which is a common procedure in 
revision surgery for deep infection (Arthursson et al. 2005, 
Espehaug et al. 2006). These procedures will, however, be 
registered if a second stage in the revision is performed and 
reported. Under-reporting will only affect our ﬁndings if the 
degree to which it happens changes over the period studied. 
Awareness of the importance of thorough reporting probably 
improved the reporting of infection over the study period, but 
a time trend evaluation of this was not done.
We found an increase in the risk of revision due to infec-
tion during the ﬁrst postoperative year for the 2002–2007 
group. This shows that the infections were revised earlier after 
index surgery in recent years. This can either be explained 
by a change in revision policy, a change in surgeons’ aware-
ness, or more acute infections. Current recommendations for 
early surgical site infection involve early soft tissue debride-
ment and exchange of prosthesis parts (Zimmerli and Ochsner 
2003). In our material, we found a shift from use of monob-
lock prostheses to more frequent use of modular prostheses. 
Early revision due to infection in the case of modular prosthe-
ses will therefore involve the exchange of a femoral head, an 
acetabular liner, or both, and the procedure should therefore 
be reported to the registry. Early revisions for infection in the 
case of monoblock prostheses will not, however, be reported if 
a successful soft tissue debridement combined with antibiotic 
treatment heals the infection and the prosthesis is retained. 
We adjusted for monoblock or modular prosthesis in our Cox 
analysis, to adjust for changes in reporting of deep infec-
tion due to these changes in the use of implants. In addition, 
because of the possible “under-reporting” of deep infection in 
the monoblock group, we also performed separate analyses on 
Charnley monoblock prostheses and found an increase in risk 
of infection in this group as well. 
Improvements in the design of prostheses and surgical tech-
nique have reduced the incidence of aseptic loosening in recent 
years (Herberts and Malchau 2000, Morscher 2003). This 
could affect surgeons’ awareness of low-grade infection when 
deciding on the clinical diagnosis to report after surgery. 
The problem of confounding factors and time-dependent 
risk factors in our registry study is the reason why we must 
interpret the evaluation of the risk factors and prophylactic 
measures in Table 3 with caution. The evaluation was made to 
illustrate the effect of these factors in this study, and the study 
was not set up to assess each covariate independently.
Due to the small numbers of infections, large numbers of 
primary THAs are needed to study different aspects of peri-
prosthetic infections. There is a need for improved monitor-
ing of time trends and evaluation of prophylactic measures 
concerning deep infection. For this purpose, surveillance 
programs such as the National Nosocomial Infections Surveil-
lance (NNIS) System Reports (USA) and the European sur-
veillance HELICS-SSI database could be of value, as could 
the increasing number of national arthroplasty registries and 
improved collaboration between these. Concentration on 
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and improvement of prophylaxis, diagnostics, and treatment 
of these infections will be of great importance to limit any 
increase in this serious complication. 
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